Market Research Logo

Europe Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017

Europe Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Gastrointestinal Stromal Tumor patients study in a new report ‘Europe Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Gastrointestinal Stromal Tumor epidemiology, Gastrointestinal Stromal Tumor diagnosed patients, and Gastrointestinal Stromal Tumor treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Gastrointestinal Stromal Tumor derived from epidemiological analysis, percentage of patients diagnosed with Gastrointestinal Stromal Tumor, and percentage of patients treated with a therapy.

The study helps executives estimate Gastrointestinal Stromal Tumor market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Gastrointestinal Stromal Tumor prevalence, Gastrointestinal Stromal Tumor diagnosis rate, and Gastrointestinal Stromal Tumor treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Gastrointestinal Stromal Tumor Patient Flow
  • Gastrointestinal Stromal Tumor Prevalence
  • Gastrointestinal Stromal Tumor Diagnosed Patients
  • Gastrointestinal Stromal Tumor Treated Patients


1. Gastrointestinal Stromal Tumor: Disease Definition
2. Gastrointestinal Stromal Tumor Patient Flow in Europe
2A. Gastrointestinal Stromal Tumor Prevalence in Europe
2B. Gastrointestinal Stromal Tumor Diagnosed Patients in Europe
2C. Gastrointestinal Stromal Tumor Treated Patients in Europe
3. Gastrointestinal Stromal Tumor Patient Flow in Germany
3A. Gastrointestinal Stromal Tumor Prevalence in Germany
3B. Gastrointestinal Stromal Tumor Diagnosed Patients in Germany
3C. Gastrointestinal Stromal Tumor Treated Patients in Germany
4. Gastrointestinal Stromal Tumor Patient Flow in France
4A. Gastrointestinal Stromal Tumor Prevalence in France
4B. Gastrointestinal Stromal Tumor Diagnosed Patients in France
4C. Gastrointestinal Stromal Tumor Treated Patients in France
5. Gastrointestinal Stromal Tumor Patient Flow in Spain
5A. Gastrointestinal Stromal Tumor Prevalence in Spain
5B. Gastrointestinal Stromal Tumor Diagnosed Patients in Spain
5C. Gastrointestinal Stromal Tumor Treated Patients in Spain
6. Gastrointestinal Stromal Tumor Patient Flow in Italy
6A. Gastrointestinal Stromal Tumor Prevalence in Italy
6B. Gastrointestinal Stromal Tumor Diagnosed Patients in Italy
6C. Gastrointestinal Stromal Tumor Treated Patients in Italy
7. Gastrointestinal Stromal Tumor Patient Flow in UK
7A. Gastrointestinal Stromal Tumor Prevalence in UK
7B. Gastrointestinal Stromal Tumor Diagnosed Patients in UK
7C. Gastrointestinal Stromal Tumor Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Gastrointestinal Stromal Tumor Patient Flow in Europe, 2016
Table 2: Gastrointestinal Stromal Tumor Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Gastrointestinal Stromal Tumor Patient Flow in Germany, 2016
Table 4: Gastrointestinal Stromal Tumor Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Gastrointestinal Stromal Tumor Patient Flow in France, 2016
Table 6: Gastrointestinal Stromal Tumor Patient Flow Forecast in France, 2016 - 2025
Table 7: Gastrointestinal Stromal Tumor Patient Flow in Spain, 2016
Table 8: Gastrointestinal Stromal Tumor Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Gastrointestinal Stromal Tumor Patient Flow in Italy, 2016
Table 10: Gastrointestinal Stromal Tumor Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Gastrointestinal Stromal Tumor Patient Flow in UK, 2016
Table 12: Gastrointestinal Stromal Tumor Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Gastrointestinal Stromal Tumor Patient Flow in Europe, 2016
Figure 2: Gastrointestinal Stromal Tumor Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Gastrointestinal Stromal Tumor Patient Flow in Germany, 2016
Figure 4: Gastrointestinal Stromal Tumor Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Gastrointestinal Stromal Tumor Patient Flow in France, 2016
Figure 6: Gastrointestinal Stromal Tumor Patient Flow Forecast in France, 2016 - 2025
Figure 7: Gastrointestinal Stromal Tumor Patient Flow in Spain, 2016
Figure 8: Gastrointestinal Stromal Tumor Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Gastrointestinal Stromal Tumor Patient Flow in Italy, 2016
Figure 10: Gastrointestinal Stromal Tumor Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Gastrointestinal Stromal Tumor Patient Flow in UK, 2016
Figure 12: Gastrointestinal Stromal Tumor Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report